|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:22AM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 12:39PM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:57PM
|
|
Re: Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 14, 2019 07:08AM
|
|
Re: Bioasis board very quiet with a flat share price
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2021 06:13PM
|
|
Re: Bioasis Completes Bridge Financing Transaction
|
2
|
BIOASIS TECHNOLOGIES INC
|
Dec 28, 2019 05:56AM
|
|
Re: BiOasis Presents at BIO Investor Forum Oct 17th
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 09, 2018 06:39AM
|
|
Re: Bioasis to Host Annual General Meeting Webcast on December 5, 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Dec 08, 2019 01:44PM
|
|
Re: Bioasis to Host Annual General Meeting Webcast on December 5, 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Dec 08, 2019 02:31PM
|
|
Re: Bioasis to Host Annual General Meeting Webcast on December 5, 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 28, 2019 09:42AM
|
|
Re: BioBoss
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 07, 2019 10:32AM
|
|
Re: BioBoss
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 05, 2019 03:42PM
|
|
Re: BioBoss
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 07, 2019 06:54AM
|
|
Re: Biogen CTAD webcast starting now
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 11:56AM
|
|
Re: Biogen CTAD webcast starting now
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 12:19PM
|
|
Re: Biogen CTAD webcast starting now
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 01:19PM
|
|
Re: Biogen looks to FDA for approval of early Alzheimers drug.
|
2
|
Resverlogix Corp.
|
Oct 22, 2019 09:03AM
|
|
Re: Biogen looks to FDA for approval of early Alzheimers drug.
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 10:21AM
|
|
Re: Biogen vs. Resverlogix, CTAD December 5
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 06:09PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 03:37PM
|
